Akero Therapeutics, Inc. General and Administrative Expense
Akero Therapeutics, Inc. reported General and Administrative Expense of $11.35 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2025-11-07
- Akero Therapeutics, Inc. general and administrative expense for the quarter ending 2025-09-30 was $11.35M, a 19.87% increase year-over-year.
- Akero Therapeutics, Inc. general and administrative expense for the quarter ending 2025-06-30 was $11.62M, a 11.52% increase year-over-year.
- Akero Therapeutics, Inc. general and administrative expense for the quarter ending 2025-03-31 was $11.31M, a 21.61% increase year-over-year.
- Akero Therapeutics, Inc. general and administrative expense for the quarter ending 2024-12-31 was $8.73M, a 2.96% increase year-over-year.
- Akero Therapeutics, Inc. general and administrative expense for fiscal 2024 was $37.93M, a 22.06% increase from fiscal 2023.
- Akero Therapeutics, Inc. general and administrative expense for fiscal 2023 was $31.07M, a 4.02% increase from fiscal 2022.
- Akero Therapeutics, Inc. general and administrative expense for fiscal 2022 was $29.87M, a 56.18% increase from fiscal 2021.
- Akero Therapeutics, Inc. general and administrative expense for fiscal 2021 was $19.13M, a 25.52% increase from fiscal 2020.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $11.35M 10-Q · filed 2025-11-07 | $22.97M derived: sum of 2 quarters · filed 2025-11-07 | $34.29M 10-Q · filed 2025-11-07 | $43.02M derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-06-30 | $11.62M 10-Q · filed 2025-08-08 | $22.93M 10-Q · filed 2025-08-08 | $31.67M derived: sum of 3 quarters · filed 2025-08-08 | $41.14M derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-03-31 | $11.31M 10-Q · filed 2025-05-12 | $20.05M derived: sum of 2 quarters · filed 2025-05-12 | $29.52M derived: sum of 3 quarters · filed 2025-11-07 | $39.94M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-12-31 | $8.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $18.20M derived: sum of 2 quarters · filed 2025-11-07 | $28.62M derived: sum of 3 quarters · filed 2025-11-07 | $37.93M 10-K · filed 2025-02-28 |
| 2024-09-30 | $9.47M 10-Q · filed 2025-11-07 | $19.89M derived: sum of 2 quarters · filed 2025-11-07 | $29.19M 10-Q · filed 2025-11-07 | $37.67M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $10.42M 10-Q · filed 2025-08-08 | $19.72M 10-Q · filed 2025-08-08 | $28.20M derived: sum of 3 quarters · filed 2025-08-08 | $36.19M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $9.30M 10-Q · filed 2025-05-12 | $17.79M derived: sum of 2 quarters · filed 2025-05-12 | $25.77M derived: sum of 3 quarters · filed 2025-05-12 | $33.41M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $8.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $16.46M derived: sum of 2 quarters · filed 2025-02-28 | $24.11M derived: sum of 3 quarters · filed 2025-02-28 | $31.07M 10-K · filed 2025-02-28 |
| 2023-09-30 | $7.98M 10-Q · filed 2024-11-08 | $15.63M derived: sum of 2 quarters · filed 2024-11-08 | $22.59M 10-Q · filed 2024-11-08 | $29.69M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $7.64M 10-Q · filed 2024-08-09 | $14.61M 10-Q · filed 2024-08-09 | $21.71M derived: sum of 3 quarters · filed 2025-02-28 | $32.71M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $6.97M 10-Q · filed 2024-05-10 | $14.07M derived: sum of 2 quarters · filed 2025-02-28 | $25.07M derived: sum of 3 quarters · filed 2025-02-28 | $31.30M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $18.10M derived: sum of 2 quarters · filed 2025-02-28 | $24.34M derived: sum of 3 quarters · filed 2025-02-28 | $29.87M 10-K · filed 2025-02-28 |
| 2022-09-30 | $11.00M 10-Q · filed 2023-11-13 | $17.23M derived: sum of 2 quarters · filed 2023-11-13 | $22.77M 10-Q · filed 2023-11-13 | $27.50M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $6.23M 10-Q · filed 2023-08-11 | $11.77M 10-Q · filed 2023-08-11 | $16.50M derived: sum of 3 quarters · filed 2024-02-29 | $21.38M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $5.54M 10-Q · filed 2023-05-15 | $10.27M derived: sum of 2 quarters · filed 2024-02-29 | $15.15M derived: sum of 3 quarters · filed 2024-02-29 | $20.14M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $9.61M derived: sum of 2 quarters · filed 2024-02-29 | $14.60M derived: sum of 3 quarters · filed 2024-02-29 | $19.13M 10-K · filed 2024-02-29 |
| 2021-09-30 | $4.88M 10-Q · filed 2022-11-04 | $9.87M derived: sum of 2 quarters · filed 2022-11-04 | $14.40M 10-Q · filed 2022-11-04 | $18.47M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $4.99M 10-Q · filed 2022-08-05 | $9.52M 10-Q · filed 2022-08-05 | $13.59M derived: sum of 3 quarters · filed 2022-08-05 | $17.75M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $4.53M 10-Q · filed 2022-05-06 | $8.60M derived: sum of 2 quarters · filed 2022-05-06 | $12.76M derived: sum of 3 quarters · filed 2022-05-06 | $16.18M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $4.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $8.23M derived: sum of 2 quarters · filed 2022-02-25 | $11.65M derived: sum of 3 quarters · filed 2022-02-25 | $15.24M 10-K · filed 2022-02-25 |
| 2020-09-30 | $4.16M 10-Q · filed 2021-11-12 | $7.58M derived: sum of 2 quarters · filed 2021-11-12 | $11.16M 10-Q · filed 2021-11-12 | $14.25M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $3.42M 10-Q · filed 2021-08-13 | $7.00M 10-Q · filed 2021-08-13 | $10.09M derived: sum of 3 quarters · filed 2022-02-25 | $12.51M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $3.59M 10-Q · filed 2021-05-13 | $6.67M derived: sum of 2 quarters · filed 2022-02-25 | $9.10M derived: sum of 3 quarters · filed 2022-02-25 | $10.74M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $5.51M derived: sum of 2 quarters · filed 2022-02-25 | $7.16M derived: sum of 3 quarters · filed 2022-02-25 | $8.61M 10-K · filed 2022-02-25 |
| 2019-09-30 | $2.42M 10-Q · filed 2020-11-12 | $4.07M derived: sum of 2 quarters · filed 2020-11-12 | $5.52M 10-Q · filed 2020-11-12 | $6.51M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $1.65M 10-Q · filed 2020-08-12 | $3.10M 10-Q · filed 2020-08-12 | $4.08M derived: sum of 3 quarters · filed 2020-08-12 | $4.56M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $1.45M 10-Q · filed 2020-05-13 | $2.43M derived: sum of 2 quarters · filed 2020-05-13 | $2.91M derived: sum of 3 quarters · filed 2020-05-13 | $3.15M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.46M derived: sum of 2 quarters · filed 2020-03-16 | $1.70M derived: sum of 3 quarters · filed 2020-03-16 | $1.90M 10-K · filed 2020-03-16 |
| 2018-09-30 | $474.00K 10-Q · filed 2019-11-12 | $716.00K derived: sum of 2 quarters · filed 2019-11-12 | $911.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $242.00K 10-Q · filed 2019-08-12 | $437.00K 10-Q · filed 2019-08-12 |